The company reported net sales of $807.2 million for the Q2 2024 3-month period (versus $846.2 million a year earlier), diluted EPS of $1.86 (versus $1.82), and adjusted diluted EPS of $2.06 (versus $2.18). Organic net sales fell 4%.

1. 01

   The company reported net sales of $807.2 million for the Q2 2024 3-month period (versus $846.2 million a year earlier), diluted EPS of $1.86 (versus $1.82), and adjusted diluted EPS of $2.06 (versus $2.18). Organic net sales fell 4%.

2. 02

   IDEX said organic net sales for Q2 fell 11% in the Health & Science Technologies segment and rose 1% in the Fire & Safety/Diversified Products segment, while the Fluid & Metering Technologies segment was unchanged. The company cited lower volumes in the HST segment as the main factor behind the overall 4% decline.

3. 03

   IDEX reported operating cash flow of $133.6 million (versus $141.2 million) and free cash flow of $117.7 million (versus $119.6 million) for Q2 3-month period. Free cash flow for the 6-month period to date was $254.3 million (versus $240.9 million).

4. 04

   The company said it entered into a definitive agreement on July 23, 2024 to acquire Mott Corporation for cash consideration of $1.0 billion (subject to customary adjustments), with closing expected by the end of Q3. It said its full-year GAAP diluted EPS outlook is now $6.85 to $6.95, down from the previous outlook of $7.13 to $7.43.

Analysis scope · Filing body and confirmed press-release exhibitWe analyzed the filing body and confirmed exhibits. This is not a review of other exhibits, investor presentations or the full earnings call.

AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.

Original filing

The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.